Jul 6, 2026 04:05PM
Jul 6, 2026 04:05PM
Jun 16, 2026 10:30AM
May 28, 2026 06:06AM
May 7, 2026 04:05PM
Apr 28, 2026 04:30PM
Apr 28, 2026 04:30PM Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®
Apr 6, 2026 05:30PM
Apr 6, 2026 05:30PM
Feb 26, 2026 04:05PM
Dec 23, 2025 04:06PM
Dec 23, 2025 04:05PM
Dec 15, 2025 04:39PM
Dec 15, 2025 04:25PM Organogenesis plans to file BLA for ReNu knee osteoarthritis treatment
Dec 15, 2025 04:25PM
Nov 6, 2025 04:05PM
Nov 3, 2025 01:10PM
Sep 26, 2025 06:45AM
Sep 25, 2025 04:50PM
Sep 25, 2025 04:50PM
Aug 7, 2025 04:05PM Organogenesis Holdings Inc. Reports Second Quarter 2025 Financial Results
Jul 15, 2025 09:01AM
Jul 15, 2025 09:00AM
May 8, 2025 04:05PM
Feb 27, 2025 04:05PM
Nov 15, 2024 09:25AM
Nov 12, 2024 04:05PM
Aug 8, 2024 04:09PM Organogenesis Holding (ORGO) Issues ReNu Program Update
Aug 8, 2024 04:05PM
Aug 8, 2024 04:04PM
May 9, 2024 04:05PM
May 2, 2024 07:00AM
May 2, 2024 07:00AM
Feb 29, 2024 04:05PM
Nov 9, 2023 04:05PM Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results
Aug 9, 2023 04:05PM
May 10, 2023 04:05PM
Apr 27, 2023 07:30AM
Apr 27, 2023 07:30AM
Mar 27, 2023 08:03AM
Mar 27, 2023 08:00AM
Mar 1, 2023 04:02PM Organogenesis Holdings Inc. Reports Fourth Quarter 2022 and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Guidance
Nov 9, 2022 04:05PM
Aug 15, 2022 07:00AM
Aug 9, 2022 04:05PM
May 10, 2022 04:05PM
May 5, 2022 05:23PM
May 5, 2022 04:05PM
Mar 1, 2022 04:05PM Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2021 Financial Results; Introduces Fiscal Year 2022 Guidance
Feb 7, 2022 09:00PM

325,881 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All